Literature DB >> 2521226

Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality.

E R Bates1, R M Califf, R S Stack, L Aronson, B S George, R J Candela, D J Kereiakes, C W Abbottsmith, L Anderson, B Pitt.   

Abstract

The influence of infarct location on arterial patency, left ventricular function and mortality after 150 mg of intravenous recombinant tissue-type plasminogen activator (rt-PA) and selective coronary angioplasty was studied in 386 patients with acute myocardial infarction. In 329 patients with acute and 1 week angiograms, the 90 min infarct-related artery patency rate after rt-PA in the left anterior descending, the left circumflex and the right coronary artery was 77, 68 and 68%, respectively. Angioplasty, performed in half the patients, resulted in a final acute patency rate of 93%, which was not related to arterial distribution. Repeat catheterization and revascularization were required in 12% of patients before day 7 and were independent of arterial distribution. The reocclusion rate for the right coronary artery (21%) was higher than that for the left anterior descending (12%) or left circumflex (5%) artery (p = 0.01). Acute and 1 week contrast ventriculograms suitable for analysis were available in 266 patients. Whereas serial left ventricular ejection fraction did not improve during the course of this study, serial regional wall motion (centerline chord method) improved in each arterial distribution. The in-hospital mortality rate of 6% was not related to arterial distribution, although death was twice as likely with proximal compared with distal lesions. Ten of 11 patients who died in the group with the left anterior descending artery as the infarct-related artery had a lesion proximal to the first septal perforator branch.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2521226     DOI: 10.1016/0735-1097(89)90542-1

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  What's the point of ST elevation?

Authors:  S D Carley; R Gamon; P A Driscoll; G Brown; P Wallman
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

3.  Impact of early accelerated dose tissue plasminogen activator on in-hospital patency of the infarcted vessel in patients with acute right ventricular infarction.

Authors:  E Giannitsis; J Potratz; U Wiegand; U Stierle; H Djonlagic; A Sheikhzadeh
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

4.  Possible association of a reduction in cardiovascular events with blood donation.

Authors:  D G Meyers; D Strickland; P A Maloley; J K Seburg; J E Wilson; B F McManus
Journal:  Heart       Date:  1997-08       Impact factor: 5.994

5.  Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.

Authors:  Miguel Quintana; Paul Hjemdahl; Alf Sollevi; Thomas Kahan; Magnus Edner; Nina Rehnqvist; Eva Swahn; Ann-Catrin Kjerr; Per Näsman
Journal:  Eur J Clin Pharmacol       Date:  2003-03-18       Impact factor: 2.953

6.  Short- and Long-Term Outcomes in Patients With Right Ventricular Infarction According to Modalities of Reperfusion Strategies in China: Data From China Acute Myocardial Infarction Registry.

Authors:  Mengjin Hu; Ge Chen; Hongmei Yang; Xiaojin Gao; Jingang Yang; Haiyan Xu; Yuan Wu; Lei Song; Shubin Qiao; Fenghuan Hu; Yang Wang; Wei Li; Chen Jin; Yuejin Yang
Journal:  Front Cardiovasc Med       Date:  2022-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.